engleski

Esomeprasole versus Pantoprazole for healing erosive oesophagitis

The aim of this study was to compare the efficacy of esomeprazole and pantoprazole with regard to healing and relief from gastroesophageal reflux disease-related symptoms. In this multicentre, randomized, single-blind study 180 patients ( ITT population ) diagnosed with endoscopically proven GERD grade A, B, C received esomeprazole ( 40 mg once daily (o.d), n=90 ) or pantoprazole ( 40 mg o.d., n= 90 ). Healing and relief from GERD-related symptoms were assessed at first and final visit ( after 4 or 8 weeks of treatment ). Esomeprazole 40 mg provided significantly greater healing than pantoprazole 40 mg after 4 weeks of treatment in patients with EE ( 77.8 % vs. 91.1 % ). The proportion of heartburn-free days was similar in patients treated with esomeprazole and to those treated with pantoprazole.

GERD; esomeprazole; pantoprazole

nije evidentirano